Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NVO

Novo Nordisk ADR

Nov 06 • 04:00PM ET

46.51

-1.95 -4.02 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN PFE SNY BMY GSK

| Held by: PPH AVDE PVAL WCMI PID RVER APIE DFIC DIVZ OZEM

Scroll to Statements

Index	-	P/E	13.55	EPS (ttm)	3.43	Insider Own	0.01%	Shs Outstand	3.37B	Perf Week	-7.05%
Market Cap	156.56B	Forward P/E	12.17	EPS next Y	3.82	Insider Trans	0.00%	Shs Float	3.37B	Perf Month	-21.98%
Enterprise Value	167.36B	PEG	1.57	EPS next Q	0.94	Inst Own	8.62%	Short Float	0.79%	Perf Quarter	-8.95%
Income	15.29B	P/S	3.35	EPS this Y	15.36%	Inst Trans	-1.50%	Short Ratio	1.72	Perf Half Y	-28.28%
Sales	46.69B	P/B	7.73	EPS next Y	4.82%	ROA	21.83%	Short Interest	26.67M	Perf YTD	-45.93%
Book/sh	6.02	P/C	30.52	EPS next 5Y	8.63%	ROE	68.30%	52W High	112.52 -58.67%	Perf Year	-57.61%
Cash/sh	1.52	P/FCF	15.65	EPS past 3/5Y	25.78% 21.74%	ROIC	37.50%	52W Low	45.05 3.24%	Perf 3Y	-12.60%
Dividend Est.	1.77 (3.81%)	EV/EBITDA	7.27	Sales past 3/5Y	23.46% 18.15%	Gross Margin	81.93%	Volatility	4.34% 2.56%	Perf 5Y	45.59%
Dividend TTM	1.73 (3.71%)	EV/Sales	3.58	EPS Y/Y TTM	24.50%	Oper. Margin	42.41%	ATR (14)	1.74	Perf 10Y	75.31%
Dividend Ex-Date	Aug 18, 2025	Quick Ratio	0.57	Sales Y/Y TTM	18.71%	Profit Margin	32.76%	RSI (14)	21.01	Recom	1.97
Dividend Gr. 3/5Y	28.20% 21.81%	Current Ratio	0.78	EPS Q/Q	-21.84%	SMA20	-11.95%	Beta	0.67	Target Price	65.40
Payout	35.93%	Debt/Eq	0.60	Sales Q/Q	11.80%	SMA50	-16.23%	Rel Volume	2.78	Prev Close	48.46
Employees	76302	LT Debt/Eq	0.52	Earnings	Nov 05 BMO	SMA200	-30.07%	Avg Volume	15.51M	Price	46.51
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.34% -3.47%	Trades		Volume	43,118,185	Change	-4.02%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral
Dec-01-23	Initiated	Cantor Fitzgerald	Overweight	$120

Show Previous Ratings

Today 05:30PM	Trump inks Eli Lilly & Novo deals: How to play pharma stocks (Yahoo Finance Video)
04:12PM	'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera (Investor's Business Daily)
04:10PM	Trump Slashes Weight-Loss Drug Prices By Up To 74% In Deal With Lilly, Novo (Investor's Business Daily)
02:30PM	Novo Nordisk's CagriSema was associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease over time in new analyses at ObesityWeek (PR Newswire)
01:31PM	Eli Lilly and Novo Nordisk cut deals with Trump to lower weight loss drug prices (Quartz)
01:18PM	Loading…
01:18PM	Novo Nordisk Has Downgraded Its Outlook for the Fourth Time This Year. Here's What Investors Need to Know. (Motley Fool)
01:17PM	President Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices (CNBC TV)
01:13PM	Eli Lilly, Novo to cut GLP-1 cost; airline stocks fall on FAA cut (Yahoo Finance Video)
12:04PM	Trump White House confirms pricing deal with weight-loss-drug giants Eli Lilly, Novo Nordisk (MarketWatch)
10:46AM	ESPN & Penn end pact, Metsera bidding war, Boeing case dismissed (Yahoo Finance Video)
10:17AM	LIVE: President Trump expected announcement on weight loss drug pricing deal 11/5/2025 (CNBC TV)
Nov-05-25 06:13PM	Expect Pfizer bid to beat Novo for Metsera, says BMO's Evan David Seigerman (CNBC TV)
04:34PM	These Stocks Moved the Most Today: AMD, Humana, Novo Nordisk, Kratos, Arista Networks, Axon, Trex, Rivian, Super Micro, and More (Barrons.com)
04:31PM	Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled (Investor's Business Daily)
03:45PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
02:31PM	Loading…
02:31PM	These Stocks Are Moving the Most Today: AMD, Humana, Novo Nordisk, Kratos, Arista Networks, Axon, Trex, Rivian, Super Micro, and More (Barrons.com)
02:29PM	Novo Nordisk Posts Mixed Q3, Trims Growth Outlook (GuruFocus.com)
02:00PM	Novo Nordisk AS (NVO) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amid Market Challenges (GuruFocus.com)
11:54AM	Novo Nordisk Slides as GLP-1 Fatigue and Pricing Risks Cloud 2025 Outlook (GuruFocus.com)
11:37AM	Amgen's Q3 Earnings & Sales Beat, 2025 Outlook Raised, Stock Up (Zacks)
10:43AM	Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears. (Barrons.com)
10:30AM	Novo Nordisk Q3 Earnings & Revenues Miss, GLP-1 Drugs Face US Hurdles (Zacks)
10:12AM	Novo Nordisk CEO Mike Doustdar on $10B Metsera bid, expanding use of obesity drugs (CNBC TV)
10:00AM	Prediction: Novo Nordisk Will Soar by 2026 (Motley Fool)
09:34AM	Novo Nordisk cuts outlook, IBM layoffs, Pinterest stock plummets (Yahoo Finance Video)
08:37AM	Novo Nordisk Skids After Cutting Its Outlook For The Third Time This Year (Investor's Business Daily)
08:18AM	McDonalds and Novo Nordisk report earnings (Yahoo Finance Video)
07:45AM	Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy (Motley Fool)
07:18AM	White House speaking with Novo Nordisk, Eli Lilly about selling some obesity drugs for $149/mo: WSJ (CNBC TV)
06:47AM	Novo Nordisk Cuts Growth Outlook as Weight-Loss Drug Pressures Rise (GuruFocus.com)
05:42AM	Loading…
05:42AM	Novo Nordisk downgrades sales outlook again amid bidding war with Pfizer for Metsera (MarketWatch)
05:30AM	These Stocks Are Moving the Most Today: AMD, Pinterest, Super Micro, Arista Networks, Axon Enterprise, AppLovin, and More (Barrons.com)
05:00AM	Novo Nordisk Stock Up After Earnings. Guidance Cut on These Weight-Loss Drug Fears. (Barrons.com)
Nov-04-25 07:00PM	Qualcomm & McDonald's earnings, ADP job data: What to Watch (Yahoo Finance Video)
05:29PM	Obesity drugs may get Medicare access under deal with White House: reports (MarketWatch)
04:17PM	Hims Says It's Negotiating A New Deal With Novo Nordisk, But Shares Slide (Investor's Business Daily)
04:12PM	Novo Sweetens Its Bid For Metsera As Takeover Drama With Pfizer Escalates (Investor's Business Daily)
01:09PM	Pfizer and Novo Nordisk both raise bids for Metsera (CNBC TV)
11:15AM	Pfizer Q3 Earnings Beat Estimates, Sales Decline as COVID Demand Cools (Zacks)
10:59AM	Pfizer & Novo boost Metsera bids, Hertz stock skyrockets (Yahoo Finance Video)
10:51AM	Hims & Hers Eyes Major Weight-Loss Breakthrough With Potential Novo Nordisk Wegovy Deal (GuruFocus.com)
08:06AM	Pfizer files second lawsuit against Metsera, Novo Nordisk (TipRanks)
07:20AM	Pfizer raises and narrows full-year earnings guidance (Investing.com)
Nov-03-25 04:26PM	Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo (Investor's Business Daily)
01:23PM	Did Novo Nordisk Just Say "Checkmate" to Pfizer? (Motley Fool)
11:41AM	Novo Nordisk Before Q3 Earnings: How Should Investors Play the Stock? (Zacks)
11:13AM	Viking Therapeutics Could Be Pharmas Next Big Buyout Target (24/7 Wall St.)
09:34AM	Kimberly-Clark to buy Tylenol maker Kenvue, Iren & Microsoft deal (Yahoo Finance Video)
07:58AM	2 Beaten-Down Stocks That Could Be About to Rally (Motley Fool)
Oct-31-25 07:00PM	SNAP benefits expire, open enrollment, earnings: What to Watch (Yahoo Finance Video)
05:26PM	Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion Deal (Investor's Business Daily)
11:07AM	Pfizer Q3 Earnings Loom: Buy, Sell or Hold PFE Stock Ahead of Results? (Zacks)
Oct-30-25 06:53PM	Mizuho's Holtz talks what is behind Novo's bid for Metsera (CNBC TV)
04:09PM	Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera (Investor's Business Daily)
02:27PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
02:16PM	Pfizer said to mull suing Novo Nordisk over Metsera bid (Investing.com)
02:11PM	Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks. (Barrons.com)
01:11PM	Chipotle drags fast casual stocks lower, Meta reports raising $125B (Yahoo Finance Video)
12:57PM	Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales (Zacks)
12:39PM	Novo Crashes Pfizer's Party with Surprise $6.5B Power Move for Metsera (GuruFocus.com)
09:25AM	Novo Nordisk's bid for Metsera, Eli Lilly boosts revenue outlook (Yahoo Finance Video)
09:13AM	Novo Nodrisk stock dips on aggressive odder to buy Metsera, reckless says Pfizer (Investing.com)
09:08AM	Novo Nordisk A/S (NVO)'s Top Investor Decides to Take Control of its Board, Reports Reuters (Insider Monkey)
08:09AM	Eli Lilly's stock jumps as Zepbound sales nearly triple at lower prices (MarketWatch)
07:11AM	Metsera Stock Soars. Novo Nordisk Looks to Outbid Pfizer for the Obesity-Drug Maker. (Barrons.com)
06:57AM	Pfizer Addresses Proposal for Metsera (Business Wire)
Oct-29-25 08:22AM	What's the Driving Force Behind Eli Lilly's Recent Acquisition Spree? (Zacks)
06:20AM	1 Incredible Reason to Buy Novo Nordisk Stock (NVO) in November -- or Sooner (Motley Fool)
05:45AM	Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be Worried? (Motley Fool)
Oct-28-25 05:45PM	Novo Nordisk (NVO) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
09:53AM	If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These (Motley Fool)
Oct-27-25 12:21PM	What Is 1 of the Best Pharmaceutical Stocks to Buy Now? (Motley Fool)
09:52AM	Buy, Sell or Hold Lilly Stock? Key Tips Ahead of Q3 Earnings (Zacks)
09:00AM	Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know (Zacks)
Oct-26-25 06:05AM	Is Omeros Corporation (OMER) One of the Hot Stocks to Buy with Huge Upside Potential? (Insider Monkey)
Oct-24-25 11:39AM	NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now? (Zacks)
Oct-23-25 10:39AM	Lilly Up 10% in a Month: Should You Buy, Sell or Hold the Stock? (Zacks)
09:55AM	How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q3 Results? (Zacks)
08:16AM	Breakout Momentum Plays You Need to Know About (MarketBeat)
07:40AM	Is Novo Nordisk (NVO) The Best Weight-Loss Stock to Buy? (Insider Monkey)
05:02AM	Strength Seen in Innoviva (INVA): Can Its 5.5% Jump Turn into More Strength? (Zacks)
Oct-22-25 10:35PM	J.P. Morgan Maintains a Buy on Novo Nordisk (NVO) (Insider Monkey)
05:59PM	Novo Nordisk A/S (NVO): A Bull Case Theory (Insider Monkey)
05:45PM	Novo Nordisk (NVO) Declines More Than Market: Some Information for Investors (Zacks)
12:48PM	Market Meltdown Coming? These 2 ETFs Are Ready to Surge If Stocks Tank (24/7 Wall St.)
11:04AM	NVO Stock Falls Amid Governance Shift as Foundation Seeks New Board (Zacks)
07:41AM	Omeros Sells Exclusive Global Rights for Drug Zaltenibart to Novo Nordisk (Insider Monkey)
04:35AM	Novo Nordisk Power Struggle Erupts: Foundation Forces Leadership Overhaul After CEO Clash (GuruFocus.com)
04:24AM	Novo Nordisk Chair and Board Members Step Down After Rift With Controlling Foundation (GuruFocus.com)
12:00AM	US pharma price probe raises threat of new drug tariffs (Financial Times)
Oct-21-25 01:19PM	HSBC's Rajesh Kumar on Novo Nordisk: We want to see management team execute turnaround strategy (CNBC TV)
09:30AM	NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients (Zacks)
09:18AM	Novo Nordisk in active talks with Trump administration on MFN (CNBC TV)
08:54AM	The Ozempic maker shakes up its board. It has been a year of turmoil for Novo Nordisk. (MarketWatch)
05:05AM	These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall (Motley Fool)
05:00AM	Did Eli Lilly Just Say "Checkmate" to Novo Nordisk? (Motley Fool)
Oct-20-25 03:45PM	Novo Nordisk Wins FDA OK for Oral Heart Drug (GuruFocus.com)
09:07AM	2 Beaten-Down Stocks to Buy and Hold for the Next Decade (Motley Fool)
04:20AM	These 3 Obesity Drug Stocks Are Set to Soar This Fall and Beyond (Motley Fool)
Oct-17-25 08:06PM	President Trump targets $150 MFN price for GLP-1s (CNBC TV)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience